LncRNA ACTA2-AS1 acts as a bladder cancer prognostic biomarker and blocks malignant advance via miR-148b-3p/DNAJB4

Xing Chen, Qunfu Tang, Yingjie Wang, Jianbin Zhang, Lei Zhou · 2026

Read LncRNA ACTA2-AS1 acts as a bladder cancer prognostic biomarker and blocks malignant advance via miR-148b-3p/DNAJB4 by Xing Chen, Qunfu Tang, Yingjie Wang, Jianbin Zhang, Lei Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13543625.txt.

Description

Xing Chen and colleagues reported in 2026 on a long non-coding RNA called ACTA2-AS1 in bladder cancer, a molecule that does not build protein but regulates other genes. Mining public databases showed the RNA scarce in tumours, and the team confirmed the pattern in tissue from 132 patients alongside cell experiments. They traced a chain in which the RNA soaks up a small regulatory RNA, freeing a protective gene called DNAJB4.

Patients with low ACTA2-AS1 had poorer differentiation, more lymph-node spread, later stage, and worse survival, making the RNA a candidate prognostic marker. In cells, restoring it slowed growth, movement, and invasion while pushing cells toward death and cycle arrest; adding back the small RNA it absorbs reversed those benefits. A tumour-suppressing sponge lost in cancer, the authors argue, helps explain malignant behaviour and could anchor future tests or therapies.

Catalog record

CREATORXing Chen, Qunfu Tang, Yingjie Wang, Jianbin Zhang, Lei Zhou
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40789
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13543625

Browse the full library · About the Tower of Babel